BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1996352)

  • 1. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.
    Yoshida R; Takikawa O; Oku T; Habara-Ohkubo A
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1526-30. PubMed ID: 1996352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allografted meth A (H-2d) tumor cells in C57BL/6 (H-2b) mice.
    Nomi H; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    Microbiol Immunol; 2007; 51(3):297-306. PubMed ID: 17380049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
    Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
    Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to reject an allografted tumor after elimination of macrophages in mice.
    Ushio Y; Yamamoto N; Sanchez-Bueno A; Yoshida R
    Microbiol Immunol; 1996; 40(7):489-98. PubMed ID: 8865154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
    Ushio-Umeda Y; Yoshida R
    Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
    Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
    Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
    Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
    Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
    Ozawa H; Iwaguchi T; Kataoka T
    J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early development of CD8-negative and CD8-positive MHC-unrestricted cytotoxic cells induced by alloantigen inoculation in mice.
    Nishi Y; Hosokawa T; Aoike A; Kawai K; Kamahora T
    Microbiol Immunol; 1990; 34(9):775-85. PubMed ID: 2126592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of killer activity of murine spleen cells against allogeneic and syngeneic tumor cells by inoculation of alloantigen in vivo.
    Nishi Y; Hosokawa T; Aoike A; Kamahora T; Sudo H; Kawai K
    Microbiol Immunol; 1987; 31(12):1245-54. PubMed ID: 2453782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.